Page last updated: 2024-09-04

rhodioloside and Nasopharyngeal Neoplasms

rhodioloside has been researched along with Nasopharyngeal Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, Y; Li, Z; Liu, S1

Other Studies

1 other study(ies) available for rhodioloside and Nasopharyngeal Neoplasms

ArticleYear
Salidroside suppresses the activation of nasopharyngeal carcinoma cells via targeting miR-4262/GRP78 axis.
    Cell cycle (Georgetown, Tex.), 2022, Volume: 21, Issue:7

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Chaperone BiP; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Mice; Mice, Nude; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phenols

2022